Chintu Patel
CIK: 0001737428
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Amneal Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Aug 10, 2026AMRX
Amneal Pharmaceuticals, Inc.
Award(A)Indirect6.4M shares- - Mar 4, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct92.6K shares- - Mar 4, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct29K shares at avg. $13.30$385K - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct17.1K shares at avg. $13.31$228K - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct315.9K shares at avg. $13.31$4.2M - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct59.9K shares- - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct733.9K shares- - Mar 2, 2026AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectPerformance-Based Restricted Stock Units
544.7K shares- - Mar 2, 2026AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
190.6K shares- - Mar 2, 2026AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectPerformance-Based Restricted Stock Units
354K shares- - Mar 4, 2025AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct46.5K shares at avg. $8.84$411K - Mar 4, 2025AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct92.6K shares- - Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
239.7K shares- - Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct579.7K shares- - Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct274.3K shares at avg. $8.76$2.4M - Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectPerformance-Based Restricted Stock Units
890.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) | 6,381,734 | - | $0 | Indirect |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 92,593 | - | $0 | Direct |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 28,983 | $13.30 | $385,474 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 17,112 | $13.31 | $227,761 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 315,885 | $13.31 | $4,204,429 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 59,931 | - | $0 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 733,944 | - | $0 | Direct |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Performance-Based Restricted Stock Units | 544,663 | - | - | Direct |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 190,632 | - | - | Direct |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Performance-Based Restricted Stock Units | 354,031 | - | - | Direct |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 46,528 | $8.84 | $411,308 | Direct |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 92,592 | - | - | Direct |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 239,726 | - | - | Direct |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 579,710 | - | - | Direct |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 274,307 | $8.76 | $2,402,929 | Direct |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Performance-Based Restricted Stock Units | 890,410 | - | - | Direct |
1-16 of 16 transactions
About Patel Chintu
Patel Chintu (SEC CIK 0001737428) files insider reports with the SEC as Co-CEO of Amneal Pharmaceuticals, Inc. (AMRX).
Signal8 holds 5 ownership filings by Patel Chintu, all Form 4s, filed between Mar 5, 2025 and Aug 12, 2026. Those filings report 16 transactions, from Mar 3, 2025 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Patel Chintu's filings is in BRIDGEWATER, NJ.
Recent filings by Patel Chintu
- Aug 10, 2026: Grant or award of AMRX shares (Form 4, code A).
- Mar 4, 2026: Option exercise of AMRX shares (Form 4, code M).
- Mar 4, 2026: Tax withholding of AMRX shares (Form 4, code F).
- Mar 3, 2026: Tax withholdings of AMRX shares (2 lines, Form 4, code F).
- Mar 3, 2026: Option exercises of AMRX shares (2 lines, Form 4, code M).
Other insiders filing for Amneal Pharmaceuticals, Inc. (AMRX)
- BUCHI J KEVIN, Director
- BOYER ANDREW S, Executive Vice President
- Kiely John, Director
- Shah Nikita, Executive Vice President
- Daly Jason B., EVP, Chief Legal Officer
- Patel Tushar Bhikhubhai, 10% Owner